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Background: Adverse events are increased in patients with chronic kidney disease (CKD) following primary percutaneous coronary intervention 
(PCI) for ST-segment myocardial infarction (STEMI). Whether this risk is due to impaired microvascular perfusion after PCI is unknown.
Methods: In the HORIZONS-AMI trial, 3,602 STEMI patients were randomly allocated to bivalirudin vs. unfractionated heparin plus glycoprotein IIb/
IIIa inhibitors. Independent core-lab adjudicated data on myocardial blush grade (MBG) and ST-segment resolution were available in 2445 patients 
undergoing PCI. CKD was defined as a creatinine clearance (CrCl) < 60 ml/min.
Results: Patients with CKD (n=392) were older (75.2 v. 57.7 years, p<0.001) and more often female (44.9% v. 18.5%, p<0.001) compared to 
non-CKD patients (n=2053). There were no differences in baseline Thrombolysis in Myocardial Infarction (TIMI) flow 3 and MBG-3 in CKD v. non-CKD 
groups (27.5% v. 25.5%, p=0.39). While TIMI-3 epicardial flow was restored similarly in both groups (85.9% v. 87.8%, p=0.27), post-procedure MBG-
3 (47.8% v. 53.2%, p=0.053) and complete (>70%) ST-segment resolution (47.4% v. 51.1%, p=0.19) were marginally less frequent with CKD. At 3 
years, cardiac mortality in patients with v. without CKD was 6.8% v. 2.6%, p<0.001.
Conclusions: Modest differences in microvascular perfusion in patients with vs. without CKD after primary PCI for STEMI are unlikely to account for 
the markedly higher mortality risk in CKD patients.
